Status:
UNKNOWN
Frozen-thawed Embryo Transfers and Hormone Substitution on Thrombotic Risk Markers
Lead Sponsor:
Horsens Hospital
Collaborating Sponsors:
Aarhus University Hospital
Conditions:
Frozen Embryo Transfer
Eligibility:
FEMALE
18-50 years
Brief Summary
The study focus on the impact of estrogen/progesterone substitution during artificial cycle frozen embryo transfer (AC-FET) in women undertaking assisted reproductive technology treatment (ART).
Detailed Description
The aim is to investigate whether the coagulation is activated in women undergoing estrogen/progesterone substitution during artificial cycle frozen embryo transfer (AC-FET) in assisted reproductive t...
Eligibility Criteria
Inclusion
- Women receiving FET with or without estrogen/progesterone substitution
Exclusion
- Known bleeding disorder
- Indication for thromboprophylaxis during ART treatment
- Treatment with anti-platelet medication including non-steroid-anti-inflammatory drugs (NSAIDs) within the last week
- Donor recipients
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04359576
Start Date
August 1 2019
End Date
December 1 2024
Last Update
April 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Horsens Regional Hospital
Horsens, Denmark, 8700